logo

For the Inventor, By the Inventor

CA

Christopher I Bayly

This inventor holds 18 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Merck Frosst Canada & Co., Axys Pharmaceuticals, Inc., Kaneq Pharma Inc.. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher I Bayly. Retrieved from https://idiyas.com/inventor/christopher-i-bayly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 72.2



Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 165(Granted Patents)


Location History:

  • Quebec, CA (2000 - 2003)
  • Beaconsfield, CA (2001 - 2016)

Company Filing History:

goldMedal7 out of 80 
 
Merck Frosst Canada & Co.
 patents
silverMedal4 out of 40 
 
Axys Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 4 
 
Kaneq Pharma Inc.
 patents
4. 3 out of 4,770 
 
Merck + Co., Inc.
 patents
5. 2 out of 40 
 
Merck Canada Inc.
 patents
6. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
7. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2016

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 9334295 - Fused aromatic PTP-1B inhibitors (2016-05-10),
2. 8927526 - Fused aromatic PTP-1B inhibitors (2015-01-06),
3. 8481742 - Fused aromatic PTP-1B inhibitors (2013-07-09),
4. 8318748 - Cathepsin cysteine protease inhibitors (2012-11-27),
5. 8168815 - Fused aromatic PTP-1B inhibitors (2012-05-01),
6. 8063105 - Renin inhibitors (2011-11-22),
7. 7973037 - Cathepsin cysteine protease inhibitors (2011-07-05),
8. 7405229 - Cathepsin cysteine protease inhibitors (2008-07-29),
9. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),
10. 7012075 - Cathepsin cysteine protease inhibitors (2006-03-14),
11. 6699856 - Pyrazinones, compositions containing such compounds and methods of use (2004-03-02),
12. 6552168 - Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 (2003-04-22),
13. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors (2002-12-24),
14. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) (2002-11-26),
15. 6465444 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors (2002-10-15),

Title: Christopher I Bayly: Pioneering Inventor from Quebec

Introduction: Christopher I Bayly is a distinguished inventor based in Quebec, Canada, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Christopher I Bayly holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Christopher I Bayly has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Christopher I Bayly has collaborated with multinational companies, innovative startups, and renowned scientists to bring his inventions to life and make a positive impact on society.

Conclusion: Christopher I Bayly's passion for innovation and his commitment to creating a sustainable future through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…